A short ultraconserved sequence drives transcription from an alternate FBN1 promoter

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 4, 2008, Pages 638-650

  Guo, Gao ^a   Bauer, Sebastian ^a   Hecht, Jochen ^a   Schulz, Marcel H ^b   Busche, Andreas ^a   Robinson, Peter N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Downstream promoter element; Fibrillin 1; Luciferase; Marfan syndrome; Ultraconservation

Indexed keywords

NUCLEAR PROTEIN; PALINDROMIC DNA;

ARTICLE; BINDING AFFINITY; ELECTROPHORESIS; EXON; FBN1 GENE; GENE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; NONHUMAN; PROMOTER REGION; SEQUENCE ANALYSIS; SPECIES CONSERVATION;

MAMMALIA;

EID: 39649102569     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.09.004     Document Type: Article

References (60)

1. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19 (1991) 2499
2. Arteaga-Solis E., Gayraud B., Lee S.Y., Shum L., Sakai L., and Ramirez F. Regulation of limb patterning by extracellular microfibrils. J Cell Biol 154 (2001) 275-281
3. ε{lunate}. Bioinformatics 16 (2000) 135-139
4. Bejerano G., Pheasant M., Makunin I., Stephen S., Kent W.J., and Mattick J.S. Ultraconserved elements in the human genome. Science 304 (2004) 1321-1325
5. Bejerano G., Lowe C.B., Ahituv N., King B., Siepel A., and Salama S.R. A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature 441 (2006) 87-90
6. Biery N.J., Eldadah Z.A., Moore C.S., Stetten G., Spencer F., and Dietz H.C. Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics 56 (1999) 70-77
7. Boyer T.G., and Maquat L.E. Minimal sequence and factor requirements for the initiation of transcription from an atypical. TATATAA box-containing housekeeping promoter. J Biol Chem 265 (1990) 20524-20532
8. Burke T.W., and Kadonaga J.T. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 11 (1997) 3020-3031
9. Carta L., Pereira L., Arteaga-Solis E., Lee-Arteaga S.Y., Lenart B., and Starcher B. Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J Biol Chem 281 (2006) 8016-8023
10. Charbonneau N.L., Dzamba B.J., Ono R.N., Keene D.R., Corson G.M., and Reinhardt D.P. Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences. J Biol Chem 278 (2003) 2740-2749
11. Colombo P., and Fried M. Functional elements of the ribosomal protein L7a (rpL7a) gene promoter region and their conservation between mammals and birds. Nucleic Acids Res 20 (1992) 3367-3373
12. ′ end. Genomics 17 (1993) 476-484
13. Corson G.M., Charbonneau N.L., Keene D.R., and Sakai L.Y. Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics 83 (2004) 461-472
14. Croager E.J., Muir T.M., and Abraham L.J. Analysis of the human and mouse promoter region of the non-Hodgkin's lymphoma-associated CD30 gene. J Interferon Cytokine Res 18 (1998) 915-920
15. Croager E.J., Gout A.M., and Abraham L.J. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 156 (2000) 1723-1731
16. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., and Corson G.M. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 (1991) 337-339
17. Faisst S., and Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20 (1992) 3-26
18. Galtier N., Gouy M., and Gautier C. SEAVIEW and PHYLO_WIN; two graphic tools for sequence alignment and molecular phylogeny. Comput Appl Biosci 12 (1996) 543-548
19. Gupta P., Putnam E., Carmical S., Kaitila I., Steinmann B., and Child A. Ten novel FBN2 mutations in congenital contractural arachnodactyly: Delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat 19 (2002) 39-48
20. Gupta P.A., Wallis D.D., Chin T.O., Northrup H., Tran-Fadulu V.T., and Towbin J.A. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet 41 (2004) e56
21. Hewetson A., and Chilton B.S. An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. J Biol Chem 278 (2003) 40177-40185
22. Hutchinson S., Furger A., Halliday D., Judge D.P., Jefferson A., and Dietz H.C. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: A potential modifier of phenotype?. Hum Mol Genet 12 (2003) 2269-2276
23. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., and Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 14 (1994) 116-127
24. Jin V.X., Singer G.A.C., Agosto-Pérez F.J., Liyanarachchi S., and Davuluri R.V. Genome-wide analysis of core promoter elements from conserved human and mouse orthologous pairs. BMC Bioinformatics 7 (2006) 114
25. Kuhn R.M., Karolchik D., Zweig A.S., Trumbower H., Thomas D.J., and Thakkapallayil A. The UCSC genome browser database: Update 2007. Nucleic Acids Res 35 (2007) D668-D673
26. Kutach A.K., and Kadonaga J.T. The downstream promoter element DPE appears to be as widely used as the TATA box in Drosophila core promoters. Mol Cell Biol 20 (2000) 4754-4764
27. Liu Y., Liu X.S., Wei L., Altman R.B., and Batzoglou S. Eukaryotic regulatory element conservation analysis and identification using comparative genomics. Genome Res 14 (2004) 451-458
28. Lo K., and Smale S.T. Generality of a functional initiator consensus sequence. Gene 182 (1996) 13-22
29. Maslen C.L., Corson G.M., Maddox B.K., Glanville R.W., and Sakai L.Y. Partial sequence of a candidate gene for the Marfan syndrome. Nature 352 (1991) 334-337
30. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., and Barre-Dirrie A. TRANSFAC and its module TRANSCompel: Transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34 (2006) D108-D110
31. Mátyás G., Alonso S., Patrignani A., Marti M., Arnold E., and Magyar I. Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome. Hum Genet 122 (2007) 23-32
32. Minth C.D., and Dixon J.E. Expression of the human neuropeptide Y gene. J Biol Chem 265 (1990) 12933-12939
33. Murphy W.J., Pevzner P.A., and O'Brien S.J. Mammalian phylogenomics comes of age. Trends Genet 20 (2004) 631-639
34. Ni J.Z., Grate L., Donohue J.P., Preston C., Nobida N., and O'Brien G. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 21 (2007) 708-718
35. Osada S., Daimon S., Nishihara T., and Imagawa M. Identification of DNA binding-site preferences for nuclear factor I-A. FEBS Lett 390 (1996) 44-46
36. Paonessa G., Gounari F., Frank R., and Cortese R. Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J 7 (1988) 3115-3123
37. Pei D.Q., and Shih C.H. Transcriptional activation and repression by cellular DNA-binding protein C/EBP. J Virol 64 (1990) 1517-1522
38. Pennacchio L.A., Ahituv N., Moses A.M., Prabhakar S., Nobrega M.A., and Shoukry M. In vivo enhancer analysis of human conserved non-coding sequences. Nature 444 (2006) 499-502
39. Pennisi E. Genomicists tackle the primate tree. Science 316 (2007) 218-221
40. Perry R.P. The architecture of mammalian ribosomal protein promoters. BMC Evol Biol 5 (2005) 15
41. Poulin F., Nobrega M.A., Plajzer-Frick I., Holt A., Afzal V., and Rubin E.M. In vivo characterization of a vertebrate ultraconserved enhancer. Genomics 85 (2005) 774-781
42. Prabhakar S., Poulin F., Shoukry M., Afzal V., Rubin E.M., and Couronne O. Close sequence comparisons are sufficient to identify human cis-regulatory elements. Genome Res 16 (2006) 855-863
43. Putnam E.A., Zhang H., Ramirez F., and Milewicz D.M. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 11 (1995) 456-458
44. Robinson P.N., Arteaga-Solis E., Baldock C., Collod-Béroud G., Booms P., and Paepe A.D. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43 (2006) 769-787
45. Roepcke S., Zhi D., Vingron M., and Arndt P.F. Identification of highly specific localized sequence motifs in human ribosomal protein gene promoters. Gene 365 (2006) 48-56
46. Sakai L.Y., Keene D.R., and Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103 (1986) 2499-2509
47. ′ upstream regions of the FBN1 gene associated with Marfan syndrome. Eur J Hum Genet 14 (2006) 876-879
48. Smale S.T., and Kadonaga J.T. The RNA polymerase II core promoter. Annu Rev Biochem 72 (2003) 449-479
49. Strauss E.C., and Orkin S.H. In vivo protein-DNA interactions at hypersensitive site 3 of the human beta-globin locus control region. Proc Natl Acad Sci USA 89 (1992) 5809-5813
50. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25 (1997) 4876-4882
51. ′ proximal promoter. Biochim Biophys Acta 1681 (2005) 88-98
52. Tommasi S., and Pfeifer G.P. Constitutive protection of E2F recognition sequences in the human thymidine kinase promoter during cell cycle progression. J Biol Chem 272 (1997) 30483-30490
53. Vijh S., Dayhoff D.E., Wang C.E., Imam Z., Ehrenberg P.K., and Michael N.L. Transcription regulation of human chemokine receptor CCR3: Evidence for a rare TATA-less promoter structure conserved between Drosophila and humans. Genomics 80 (2002) 86-95
54. Wyrwicz L.S., Gaj P., Hoffmann M., Rychlewski L., and Ostrowski J. A common cis-element in promoters of protein synthesis and cell cycle genes. Acta Biochim Pol 54 (2007) 89-98
55. ′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
56. Xu Y., Porntadavity S., and Clair D.K.S. Transcriptional regulation of the human manganese superoxide dismutase gene: The role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem J 362 (2002) 401-412
57. Yang C., Bolotin E., Jiang T., Sladek F.M., and Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389 (2007) 52-65
58. Zhang H., Hu W., and Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 129 (1995) 1165-1176
59. Zhou T., and Chiang C.M. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity. Nucleic Acids Res 30 (2002) 4145-4157
60. Zhou G.P., Wong C., Su R., Crable S.C., Anderson K.P., and Gallagher P.G. Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element. Blood 103 (2004) 4302-4309